MDM2 and cancer: 3. Strategies for Boosting Wild-Type p53 Activity in Cancer: Gene Therapy, Cytotoxic Chemotherapy, MDM2/MDMX(MDM4) Inhibitors, p53-Binding Compounds, Targeting p53 PTMs